{"id":"741ad8c1-c131-4c1b-8b46-4fb662788f7a","modelId":"5af9f040-fefc-4fb8-aed5-61a20cc7b17d","versionId":null,"locationId":"f42cb087-b4c0-49ea-97b6-d47fcfa6f304","operatorId":"c5677c1a-8c95-438d-9619-849950504010","ownerId":null,"slug":"neurolutions-ipsihand-germany-europe","status":"operational","firstSeen":"2024-06-01T00:00:00.000Z","statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":["identity_verification","access_control","security_screening"],"shiftStructure":null,"hoursPerDay":24,"siteType":"commercial","operatorConfirmed":null,"humanSupervisionOnsite":null,"locationPrecisionTier":"city_centroid","deploymentScale":"medium_11_100","siteEnvironment":"indoor","operatorType":"customer_deployed","sourceQualityTier":8,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[],"notes":"Commercial product — available for purchase in this market.","keyFacts":[],"reviewNote":"Bulk deepened — form-factor-based metadata assignment","exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":"retail","scaleTier":"commercial_10_99","contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-08-20T04:09:15.144Z","updatedAt":"2026-08-20T16:27:55.889Z","model":{"id":"5af9f040-fefc-4fb8-aed5-61a20cc7b17d","companyId":"c5677c1a-8c95-438d-9619-849950504010","modelName":"IpsiHand","slug":"neurolutions-ipsihand","description":"FDA-cleared non-invasive BCI for stroke rehabilitation. First FDA-cleared BCI for stroke recovery. It is a biometric system designed for physical AI applications. Key specifications include Form Factor: biometric, Maturity: commercial.","formFactor":"biometric","industryVertical":"healthcare","environment":"indoor","maturityStage":"commercial","lifecycleState":"active","supersededByModelId":null,"specs":{},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://medicine.washu.edu/news/stroke-recovery-device-using-brain-computer-interface-receives-fda-market-authorization/","title":"Stroke-recovery device using brain-computer interface receives FDA market authorization","sourceName":"Washington University School of Medicine"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[{"label":"Form Factor","value":"biometric"},{"label":"Maturity","value":"commercial"},{"label":"FDA De Novo and Breakthrough","value":"Washington University Medicine reported on 27 April 2021 that the Neurolutions IpsiHand Upper Extremity Rehabilitation System received FDA Breakthrough Device designation and De Novo marketing authorization, and called it the first stroke-rehab device that relies on a brain-computer interface ([WashU Medicine](https://medicine.washu.edu/news/stroke-recovery-device-using-brain-computer-interface-receives-fda-market-authorization/))."},{"label":"Exoskeleton, founders, and trial cadence","value":"WashU Medicine says IpsiHand is a wearable hand-and-wrist exoskeleton driven by ipsilateral brain signals, was co-founded in 2007 by Eric Leuthardt and Daniel Moran on technology licensed from the university, is meant for home or clinic, and that trial users trained about five days a week for 12 weeks ([WashU Medicine](https://medicine.washu.edu/news/stroke-recovery-device-using-brain-computer-interface-receives-fda-market-authorization/))."}],"createdAt":"2026-08-08T22:32:37.106Z","updatedAt":"2026-10-03T17:46:55.313Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"company":{"id":"c5677c1a-8c95-438d-9619-849950504010","name":"NeuroLutions","slug":"neurolutions","description":"NeuroLutions (now merged into Kandu, Inc.) developed the [IpsiHand](/models/ipsihand) System, the first FDA-cleared brain-computer interface device for stroke rehabilitation. The wearable BCI translates brain signals from the uninjured hemisphere into hand movement. In 2024, CMS created a dedicated Medicare reimbursement code — the first for any BCI device. Merged with Kandu Health in 2025 with 0M financing.","status":"private","founded":2007,"hq":"St. Louis, Missouri, USA","hqLat":38.6254063,"hqLng":-90.190009,"hqGeocodedAt":"2026-08-23T21:30:55.087Z","hqAddress":null,"hqPrecision":null,"website":"neurolutions.com","fundingTotal":null,"type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":50,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://medicine.washu.edu/news/stroke-recovery-device-using-brain-computer-interface-receives-fda-market-authorization/","title":"Stroke-recovery device using brain-computer interface receives FDA market authorization","sourceName":"Washington University School of Medicine"}],"keyFacts":[{"label":"FDA","value":"First FDA-cleared BCI for stroke rehab"},{"label":"Product","value":"IpsiHand"},{"label":"Type","value":"Non-invasive BCI"},{"label":"Parent","value":"Kandu Inc."}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-08-08T22:32:36.733Z","updatedAt":"2026-08-21T22:31:16.977Z"}},"version":null,"location":{"id":"f42cb087-b4c0-49ea-97b6-d47fcfa6f304","name":"Germany, Europe","slug":"germany-europe","kind":"country","parentLocationId":null,"region":"Western Europe","lat":null,"lng":null,"reviewStatus":"reviewed","aliases":[],"collisionRisk":"high","reviewNote":null,"createdAt":"2026-08-20T04:07:01.358Z","updatedAt":"2026-08-21T03:20:12.226Z"},"operator":{"id":"c5677c1a-8c95-438d-9619-849950504010","name":"NeuroLutions","slug":"neurolutions","description":"NeuroLutions (now merged into Kandu, Inc.) developed the [IpsiHand](/models/ipsihand) System, the first FDA-cleared brain-computer interface device for stroke rehabilitation. The wearable BCI translates brain signals from the uninjured hemisphere into hand movement. In 2024, CMS created a dedicated Medicare reimbursement code — the first for any BCI device. Merged with Kandu Health in 2025 with 0M financing.","status":"private","founded":2007,"hq":"St. Louis, Missouri, USA","hqLat":38.6254063,"hqLng":-90.190009,"hqGeocodedAt":"2026-08-23T21:30:55.087Z","hqAddress":null,"hqPrecision":null,"website":"neurolutions.com","fundingTotal":null,"type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":50,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://medicine.washu.edu/news/stroke-recovery-device-using-brain-computer-interface-receives-fda-market-authorization/","title":"Stroke-recovery device using brain-computer interface receives FDA market authorization","sourceName":"Washington University School of Medicine"}],"keyFacts":[{"label":"FDA","value":"First FDA-cleared BCI for stroke rehab"},{"label":"Product","value":"IpsiHand"},{"label":"Type","value":"Non-invasive BCI"},{"label":"Parent","value":"Kandu Inc."}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-08-08T22:32:36.733Z","updatedAt":"2026-08-21T22:31:16.977Z"},"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/neurolutions-ipsihand-germany-europe","url":"https://registry.deploy.report/deployments/neurolutions-ipsihand-germany-europe","name":"IpsiHand at Germany, Europe","identifier":"741ad8c1-c131-4c1b-8b46-4fb662788f7a","startDate":"2024-06-01T00:00:00.000Z","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/germany-europe","name":"Germany, Europe"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/neurolutions","name":"NeuroLutions"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/neurolutions-ipsihand","name":"IpsiHand"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"claimed-not-verified","maturity_stage":"commercial","lifecycle_state":"active","architectural_position":{"cohort":"biometric","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":0,"primary_source_types":[]}}}